Big Gain For Cabaletta Bio, Inc.

Cabaletta Bio, Inc. (CABA:NASDAQ) jumped higher at $3.61, a gain of 46.2%. On Fri, Oct 31, 2025, CABA:NASDAQ touched a New 2-Week High of $3.61. The stock got featured on our News Catalysts scanner on Fri, Oct 31, 2025 at 07:50 AM in the 'BIOTECH' category. From Fri, Oct 17, 2025, the stock recorded 30.00% Up Days and 27.27% Green Days

About Cabaletta Bio, Inc. (CABA:NASDAQ)

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its technology uses chimeric autoantibody receptor T cells that are designed to selectively bind and eliminate B cells that produce disease-causing autoantibodies while sparing normal B cells. The firm offers preclinical development for the treatment of muscle-specific kinase myasthenia gravis, mucocutaneous PV, and Hemophilia A with factor VIII, or FVIII, alloantibodies. Its products comprise of DSG3/1-CAART, MuSK-CAART, and FVIII-CAART. The firm's initial focus is on Pemphigus Vulgaris, which is an autoimmune blistering skin disease.